drugset / Trial / NCT03307005

Improving Sleep Quality in Heart Failure

NCT03307005

Phase 4 Completed 5 enrolled Johns Hopkins University
RandomizedParallel-groupDouble-blindTreatment

Summary

Poor sleep quality is common in patients with heart failure. The limited available evidence intimates that improving sleep quality in patients with heart failure may improve morbidity and quality of life in this patient population. However, there is a paucity of evidence assessing the use of effective pharmacologic therapies in heart failure. The nonbenzodiazepine, GABA receptor agonist, zolpidem, has been found to have considerable benefits over traditional benzodiazepines as a soporific medication. The investigators hypothesize that zolpidem will safely improve sleep quality in patients with heart failure.

Timeline

Start
2017-11-01
Primary completion
2019-01-25
Completion
2019-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 5 mg